Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 L-carnitine industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 process trends
2.4 product trends
2.5 Application trends
2.6 Regional trends
Chapter 3 L-carnitine Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Industry pitfalls & challenges
3.3 Growth potential analysis
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Pricing analysis, 2022
3.7 Technology landscape
3.7.1 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Russia-Ukraine War Impact on the industry
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 L-carnitine market Size and Forecast, By process 2018 - 2032
5.1 Chemical Synthesis
5.2 Bioprocess
Chapter 6 L-carnitine market Size and Forecast, By product 2018 - 2032
6.1 Food & Pharmaceutical Grade
6.2 Feed Grade
Chapter 7 L-carnitine market Size and Forecast, By Application 2018 - 2032
7.1 Healthcare products
7.2 Animal Feed
7.3 Functional Drinks
7.4 Others
Chapter 8 L-carnitine market Size and Forecast, By Region 2018 - 2032
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Malaysia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
Chapter 9 Company Profiles
9.1 Lonza Group Ltd
9.2 Northeast Pharmaceutical Group Co., Ltd
9.3 Chengda Pharmaceutical Co., Ltd
9.4 Hangzhou DayangChem Co. Ltd
9.5 Northeast Pharmaceutical Group Shengyang No. 1 Pharmaceutical Co., Ltd
9.6 Gnosis S.p.A
9.7 Sigma-Aldrich Corporation (acquired by Merck KGaA)
9.8 Ningbo Honor Chemtech Co., Ltd
9.9 Sinoway Industrial Co., Ltd
9.10 Wuhan Grand Hoyo Co., Ltd
9.11 Shanghai Kangxin Chemical Co., Ltd
9.12 Hubei Jusheng Technology Co., Ltd
9.13 Nuberg EPC
9.14 Avantor, Inc
9.15 Bioenergy Life Science, Inc
